NICE have recently published an updated guideline for secondary care cancer referrals (Suspected cancer: recognition and referral NG12 (1)) which updates the CG27 (2005) Referral guidelines for suspected cancer (2).
There have been some significant changes to the urgent (two week) referral guidance for urological cancer (see Table 1), especially with regard to the management of haematuria. On behalf of the BAUS Section of Oncology we have summarised their findings salient to our urological practice. This article is protected by copyright. All rights reserved.
BJU international. 2015 Oct 16 [Epub ahead of print]
Edward R Jefferies, Simon F Brewster, BAUS Section on Oncology
Department of Urology, Southmead Hospital, Bristol, UK. , Oxford University Hospitals NHS Trust, Oxford, UK.